GeneCentric Therapeutics, Inc. — Form D
GeneCentric Therapeutics, Inc. of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2022-09-20. The offering totals $3.5M, of which $2.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-09-20
- Form: D
- Accession: 0001529224-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.5M
- Amount sold: $2.5M
- Remaining: $1.0M
- Investors: 1
- Date of first sale: 2022-09-08
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-459294
Issuer
- Name: GeneCentric Therapeutics, Inc.
- CIK: 0001529224
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 100 CAPITOLA DRIVE, DURHAM, NC, 27713
- Phone: (919) 973-6544
Officers, directors & promoters (25)
| Name | Role | Location |
|---|
| Ellen Lubman | Director | Morristown, NJ |
| Clay Thorp | Director | Durham, NC |
| MICHAEL MILBURN | Director | Durham, NC |
| MICHAEL MILBURN | Executive Officer | Durham, NC |
| ARNOLD LEVINE | Director | Durham, NC |
| CHARLES PEROU | Director | Durham, NC |
| CHARLES PEROU | Executive Officer | Durham, NC |
| Prasanth Reddy | Director | Durham, NC |
| MYLA LAI-GOLDMAN | Director | Durham, NC |
| MYLA LAI-GOLDMAN | Executive Officer | Durham, NC |
| Don Hardison | Director | Durham, NC |
| Ellen V Lubman | Director | Durham, NC |
| Michael V Milburn | Director | Durham, NC |
| Michael V Milburn | Executive Officer | Durham, NC |
| Perou V Charles | Director | Durham, NC |
| Perou V Charles | Executive Officer | Durham, NC |
| Clay V Thorp | Director | Durham, NC |
| Myla V Lai-Goldman | Director | Durham, NC |
| Myla V Lai-Goldman | Executive Officer | Durham, NC |
| Arnold V Levine | Director | Durham, NC |
| Clay Neil Thorp | Director | Durham, NC |
| Arnold Neil Levine | Director | Durham, NC |
| David Neil Hayes | Director | Durham, NC |
| David Neil Hayes | Executive Officer | Durham, NC |
| Charles Neil Perou | Director | Durham, NC |
Other filings by this issuer (7)
More